戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 elae, including alcoholic cardiomyopathy and hepatic cirrhosis.
2 atitis C viral infection and other causes of hepatic cirrhosis.
3 s a chronically debilitating complication of hepatic cirrhosis.
4  association with advanced liver disease and hepatic cirrhosis.
5 teins which were increasing or decreasing in hepatic cirrhosis.
6 , approximately 45 msec) in 20 patients with hepatic cirrhosis, 20 healthy age-matched control subjec
7 ntrolled trial of adult patients with HE and hepatic cirrhosis admitted in our hospital.
8 s (HCV) account for the majority of cases of hepatic cirrhosis and hepatocellular carcinoma (HCC) wor
9 sorder of copper metabolism characterized by hepatic cirrhosis and neuronal degeneration due to inher
10 uated inflammatory responses and ameliorated hepatic cirrhosis and tumorigenesis.
11  such as arthritis, diabetes, heart failure, hepatic cirrhosis, and hepatocellular carcinoma.
12 ee (3%) patients (abnormal hepatic function, hepatic cirrhosis, and pneumonitis).
13                                Patients with hepatic cirrhosis are at heightened risk for osteoporosi
14 , which induces numerous endocrine diseases, hepatic cirrhosis, cardiac failure and even death.
15 ne mineral density (BMD) among patients with hepatic cirrhosis compared to non-cirrhotic healthy cont
16 n of RANTES, CCR1, and CCR5 in patients with hepatic cirrhosis, confirming activation of the CC chemo
17  autosomal recessively inherited syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermang
18 nce interval, 0.456-0.945; p = .023) whereas hepatic cirrhosis, hepatic failure, leukemia, multiple m
19 ucing CD4 T(h1) cells compared to those with hepatic cirrhosis (HFC, n=20) that had high interleukin
20 represent a novel marker for surveillance of hepatic cirrhosis in transplant recipients with chronic
21                                              Hepatic cirrhosis is accompanied by several haemodynamic
22  (median 48 pmol/liter) and in patients with hepatic cirrhosis (median 147 pmol/liter), a syndrome of
23 ts complications of iron overload, including hepatic cirrhosis, primary liver cancer, diabetes mellit
24 E) is a severe complication in patients with hepatic cirrhosis, which causes numerous hospital admiss
25                  Fibrosis is the hallmark of hepatic cirrhosis, worsening of which is probably the be